HOME >> MEDICINE >> NEWS
Johns Hopkins scientists map brain area that may aid hunt for human brain stem cells

A study led by a Johns Hopkins neurosurgeon has provided the first comprehensive map of a part of the adult human brain containing astrocytes, cells known to produce growth factors critical to the regeneration of damaged neural tissue and that potentially serve as brain stem cells. The mapping study -- using special microscopes and chemical analysis of 42 samples of brain tissue taken at autopsy from seven people, and 43 samples of tissue removed with permission from living patients as part of unrelated neurosurgical procedures -- also revealed evidence of the move of cells lining the ventricles, or ependymal cells, to the same area of the brain, a discovery expected to provide further insight into the critical relationship among ependymal cell, astrocytes and potential brain stem cells.

"Although we have not confirmed the existence of human brain stem cells in vivo or their ability to migrate to parts of the brain that need repair, what we have learned from this complete map of the lateral wall of the subventricle zone or SVZ, including the unexpected existence of ependymal cells there, suggests that additional research is warranted," says Alfredo Quinones-Hinojosa, M.D., lead author of the study and an assistant professor in the Department of Neurosurgery at the Johns Hopkins University School of Medicine. "If there is stem-cell-like activity in the SVZ, this discovery could help pave the way for a number of therapeutic treatments for treating brain cancer, neurodegenerative diseases and brain damage."

The subventricle zone refers to tissue and cells that lie next to the ventricles or tubes located in the center of the brain that act as conduits for the cerebral spinal fluid that bathes the entire brain. The ependymal layer is a layer of cells that make up the outer wall of these tubes. Behind that layer lies the SVZ.

Previous studies have shown that astrocytes located in rodent SVZs travel to the olfactory bulb, where they develop into new
'"/>

Contact: Eric Vohr
evohr1@jhmi.edu
410-955-8665
Johns Hopkins Medical Institutions
16-Feb-2006


Page: 1 2 3

Related medicine news :

1. Johns Hopkins begins aggressive screening for superbugs in children
2. Johns Hopkins develops pancreas cancer risk model
3. March of Dimes, Johnson & Johnson Pediatric Institute launch prematurity prevention partnership
4. Diagnosis and referrals for kidney disease fall well short of need, Johns Hopkins study shows
5. Johns Hopkins Childrens Center to lead largest-ever study on kidney disease in children
6. Johns Hopkins lab scientists tame overactive CF protein
7. Two tests better than one for diabetes control, Johns Hopkins expert tells doctors
8. Johns Hopkins scientists exploit novel route to reverse enlarged hearts in obese mice
9. Johns Hopkins study suggests link between caffeine dependence and family history of alcoholism
10. Johns Hopkins flu expert calls for mandatory vaccination of health care workers
11. Nov. 11 event celebrates a century of brain science at Johns Hopkins

Post Your Comments:
(Date:5/17/2013)... Goodman HealthDay Reporter , , FRIDAY, May 17 (HealthDay ... a metal detector, a musical instrument and a GPS system, ... your life if you,re having a heart attack. The ... helps doctors rapidly diagnose certain kinds of severe heart attacks, ... app currently is in the experimental stage, but it has ...
(Date:5/17/2013)... Lake Arrowhead, CA (PRWEB) May 17, 2013 ... without extra health complications, but for diabetics, treatment is ... diabetics involves additional medical care to monitor blood sugar ... an addicted diabetic properly, a drug rehab for ... the unique dietary and nutritional needs of the diabetic, ...
(Date:5/17/2013)... being openly gay appears to affect a male ... on his performance, according to a new study. ... Carolina found that an actor who is "out" ... despite stereotypes about homosexuals. "Early research showed ... between sexual orientation and established gender roles, especially ...
(Date:5/17/2013)... Liver transplants to treat a common type of liver ... HIV, according to new research. The Italian study, ... , found that the AIDS-causing virus doesn,t affect survival ... with this particular type of liver cancer, called hepatocellular ... is more aggressive in people with HIV and it ...
(Date:5/17/2013)... GA (PRWEB) May 17, 2013 The ... news on the site for women using the vaginal ... panel shows the number of claims alleging blood clots ... was created to improve the safety of patients using ... research and legal news. Visitors can find out if ...
Breaking Medicine News(10 mins):Health News:Heart Attack? Doctors Soon May Have an App for That 2Health News:Heart Attack? Doctors Soon May Have an App for That 3Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 2Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 3Health News:Gay Actors Convincing in Heterosexual Roles 2Health News:HIV No Barrier to Getting Liver Transplant, Study Finds 2Health News:Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes 2
(Date:5/16/2013)... , May 17, 2013 ... and Switzerland,s Cytos Biotechnology AG today ... a Phase 1 clinical trial with their H1N1 influenza vaccine ... technology. In this first Phase 1 clinical trial, the safety ... to protect against H1N1 influenza infection will be evaluated. ...
(Date:5/16/2013)... and SYDNEY , May 16, ... - ASX: HIN), a leading innovator of less invasive, miniaturized ... heart failure, today announced that CEO Doug Godshall ... Global Healthcare Conference at 11:00 a.m. EDT on Monday, May ... at the Sheraton New York Hotel. A live ...
(Date:5/16/2013)... 16, 2013  ULURU Inc. (OTCQB: ULUR) today announced its ... and provided a review of its operating activities. ... the previously communicated outlook for 2013: , Launching Altrazeal ... network of distribution partners to cover all major markets excluding ... ® to be marketed in approximately 50 markets by ...
Breaking Medicine Technology:A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2ULURU Inc. Reports First Quarter 2013 Financial Results 2ULURU Inc. Reports First Quarter 2013 Financial Results 3ULURU Inc. Reports First Quarter 2013 Financial Results 4ULURU Inc. Reports First Quarter 2013 Financial Results 5
Cached News: